Some Recent Trends in Studies of Human Lymphoid Cells: B-Cells, Epstein-Barr Virus, and Transformation
In this brief review we will discuss some recent trends in work on regulatory mechanisms involved in the selective expression of differentiated markers in human B-cell lines as well as the types of controls involved in the expression and function of Epstein-Barr virus (EBV) associated markers in human cells. A problem of special interest in this connection is the relation of the expression of EBV functions to the expression of “transformation”.
KeywordsBurkitt Lymphoma Ataxia Telangiectasia Somatic Cell Hybrid DAUDI Cell Viral Capsid Antigen
Unable to display preview. Download preview PDF.
- Eskeland T, Klein E (1971) Isolation of 7S IgM and kappa chains from the surface membrane of tissue culture cells derived from a Burkitt lymphoma. J Immunol 107:1367Google Scholar
- Hellriegel KP, Diehl V, Krause PH, Meier S, Blankenstein M, Busche W (1977) The significance of chromosomal findings for the differentiation between lymphoma and lymphoblastoid cell lines. In: Thierfelder S, Rodt H, Thiel E (eds) Hematology and blood transfusion. Immunological diagnosis of leukemias and lymphomas. Springer, Berlin, p. 307CrossRefGoogle Scholar
- Klein G, Giovanella B, Westman A, Stehlin J, Mumford D (1975) An EBV-genome-negative cell line established from an American Burkitt lymphoma: Receptor characteristics, EBV infectability and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319PubMedGoogle Scholar
- Klein G, Clements G, Zeuthen J, Westman A (1976b) Somatic cell hybrid between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. Int J Cancer 17:71515Google Scholar
- Luka J, Jörnvall H, Klein G (to be published) Purification and biochemical characterization of the Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) and and an associated protein with a 53K subunit.Google Scholar
- McConnell I, Klein G, Lint TF, Lachmann PJ (1978) Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. Eur J. Immunol 8:453Google Scholar
- Nilsson K (1978) Established human lymphoid cell lines as models for B-lymphocyte differentiation. In: Serrou B, Rosenfeld C (eds) Human lymphocyte differentiation: Its application to cancer. North-Holland, Amsterdam, p 307Google Scholar
- Oliver N, Francke U, Pellegrino MA (1978) Regional assignment of genes for mannose phosphate isomerase, pyruvate kinase 3, and β2-microglobulin expression on human chromosome 15 by hybridization of cells from a t(15;22) (q14;q13.3) translocation carrier. Cytogenet Cell Genet 22:506PubMedCrossRefGoogle Scholar
- Povey S, Jeremiah S, Arthur E, Ber R, Fialkow PJ, Gardiner E, Goodfellow PN, Karande A, Quintero M, Steel CM, Zeuthen J (to be published) Deficiency of malic enzyme: A possible marker for malignancy in lymphoid cells Ann Hum GenetGoogle Scholar
- Steinitz M, Izak G, Cohen S, Ehrenfeld M, Flechner J (to be published) Continuous production of rheumatoid factor by in vitro EBV-transformed lymphocytes. NatureGoogle Scholar
- Van den Berghe, H, Parloir C, Gosseye S, Englebienne V, Cornu G, Sokal G (1979) Variant translocation in Burkitt lymphoma Cancer Genet Cytogenet 1:9Google Scholar
- Zeuthen J, Klein G, Ber R, Masucci G, Bisballe S, Povey S, Terasaki P, Ralph P (to be published) Human lymphoma/lymphoma and lymphoma/leukemia hybrids. I. Isolation, characterization, cell surface and B-cell marker studies. J Natl Cancer InstGoogle Scholar